LL-37 5 mg
LL-37 · 5mg
The human cathelicidin antimicrobial peptide, studied in innate immunity, antimicrobial activity, inflammation and tissue repair.
- Research focus: host defence, antimicrobial activity, biofilms, wound biology
- Evidence: broad mechanistic and preclinical literature, limited therapeutic clinical evidence
- Format: research vial
What is LL-37?
LL-37 is a 37-residue peptide and the only human cathelicidin-derived antimicrobial peptide.
Why is LL-37 scientifically interesting?
It has been studied for direct antimicrobial effects as well as immune signalling, chemotaxis, angiogenesis, inflammation and wound closure.
How strong is the evidence?
Its biological role is well established, but translating that biology into a safe therapeutic product remains an active research problem.
Research-use restriction
For laboratory research use only. Not for human or veterinary use, consumption, diagnosis, treatment or administration. Availability remains unconfirmed until the specific supplier, stock and batch documentation are verified.